Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2011 Jul 31;18(2):280–288. doi: 10.1016/j.bbmt.2011.07.024

Table 4.

CIBMTR Cytogenetics Grouping Schema

Group Abnormality HRb p value

Favorable Inv(16) (without complex karyotype) 0.5 0.030
Normal 1.0 Reference
t(8;21) 1.1 0.8
11q23 abnormality 1.1 0.7
Intermediate Trisomy/tetrasomy 8 1.2 0.5
Abnormal 5 or 7 1.3 0.3
Complex (3 abnormalities) 1.1 0.7
Inv(16) with complex karyotype 1.0 1.0
Other abnormalitiesa 1.1 0.7
Adverse Complex (4 abnormalities) 1.5 0.10
Complex (5+ abnormalities) 2.3 <0.0001
a

Except for abn12p, abn3q, del(9q), t(1;19), t(9;22), t(6;9), which are not classified in this schema

b

Compared to normal karyotype